State of Wisconsin Investment Board’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.96M | Sell |
130,993
-29,171
| -18% | -$648K | 0.01% | 1218 |
|
|
2025
Q4 | $4.15M | Buy |
160,164
+5,577
| +4% | +$133K | 0.01% | 1077 |
|
|
2025
Q3 | $3.98M | Buy |
154,587
+20,857
| +16% | +$512K | 0.01% | 1043 |
|
|
2025
Q2 | $3.2M | Buy |
133,730
+17,706
| +15% | +$446K | 0.01% | 1103 |
|
|
2025
Q1 | $2.88M | Sell |
116,024
-34,154
| -23% | -$818K | 0.01% | 1118 |
|
|
2024
Q4 | $2.83M | Sell |
150,178
-32,230
| -18% | -$566K | 0.01% | 1157 |
|
|
2024
Q3 | $2.75M | Buy |
182,408
+69,146
| +61% | +$1.18M | 0.01% | 1195 |
|
|
2024
Q2 | $3.24M | Buy |
113,262
+23,623
| +26% | +$672K | 0.01% | 1105 |
|
|
2024
Q1 | $2.62M | Buy |
89,639
+12,756
| +17% | +$392K | 0.01% | 1166 |
|
|
2023
Q4 | $2.59M | Buy |
76,883
+35,377
| +85% | +$1.04M | 0.01% | 1175 |
|
|
2023
Q3 | $1.27M | Sell |
41,506
-2,308
| -5% | -$83.2K | ﹤0.01% | 1342 |
|
|
2023
Q2 | $1.76M | Sell |
43,814
-13,751
| -24% | -$569K | ﹤0.01% | 1331 |
|
|
2023
Q1 | $2.35M | Buy |
57,565
+11,551
| +25% | +$460K | 0.01% | 1253 |
|
|
2022
Q4 | $1.78M | Buy |
46,014
+545
| +1% | +$26.5K | 0.01% | 1347 |
|
|
2022
Q3 | $2.42M | Sell |
45,469
-2,742
| -6% | -$152K | 0.01% | 1294 |
|
|
2022
Q2 | $2.81M | Sell |
48,211
-10,789
| -18% | -$707K | 0.01% | 1271 |
|
|
2022
Q1 | $4.5M | Hold |
59,000
| – | – | 0.01% | 1199 |
|
|
2021
Q4 | $3.55M | Hold |
59,000
| – | – | 0.01% | 1134 |
|
|
2021
Q3 | $3.3M | Hold |
59,000
| – | – | 0.01% | 1164 |
|
|
2021
Q2 | $3.58M | Hold |
59,000
| – | – | 0.01% | 1147 |
|
|
2021
Q1 | $4.13M | Hold |
59,000
| – | – | 0.01% | 1080 |
|
|
2020
Q4 | $3.53M | Sell |
59,000
-7,300
| -11% | -$427K | 0.01% | 1086 |
|
|
2020
Q3 | $3.99M | Hold |
66,300
| – | – | 0.01% | 1005 |
|
|
2020
Q2 | $3.48M | Buy |
66,300
+3,000
| +5% | +$125K | 0.01% | 989 |
|
|
2020
Q1 | $2.12M | Buy |
63,300
+2,400
| +4% | +$99.7K | 0.01% | 1050 |
|
|
2019
Q4 | $2.76M | Hold |
60,900
| – | – | 0.01% | 1090 |
|
|
2019
Q3 | $2.32M | Buy |
60,900
+3,000
| +5% | +$120K | 0.01% | 995 |
|
|
2019
Q2 | $2.52M | Buy |
57,900
+5,000
| +9% | +$212K | 0.01% | 980 |
|
|
2019
Q1 | $2.01M | Buy |
52,900
+12,100
| +30% | +$472K | 0.01% | 1008 |
|
|
2018
Q4 | $1.75M | Buy |
40,800
+200
| +0.5% | +$9.34K | 0.01% | 995 |
|
|
2018
Q3 | $2M | Hold |
40,600
| – | – | 0.01% | 1044 |
|
|
2018
Q2 | $1.3M | Buy |
40,600
+1,200
| +3% | +$41.4K | ﹤0.01% | 1081 |
|
|
2018
Q1 | $1.23M | Hold |
39,400
| – | – | ﹤0.01% | 1065 |
|
|
2017
Q4 | $1.8M | Buy |
39,400
+10,400
| +36% | +$412K | ﹤0.01% | 990 |
|
|
2017
Q3 | $1.09M | Hold |
29,000
| – | – | ﹤0.01% | 1073 |
|
|
2017
Q2 | $1.38M | Buy |
+29,000
| New | +$1.35M | ﹤0.01% | 1001 |
|
Other funds holding PCRX
DPCM
VPM
VCM
State of Wisconsin Investment Board's PCRX Position: Q1 2026 in Review
State of Wisconsin Investment Board reduced its Pacira BioSciences (PCRX) stake by 18% in Q1 2026, selling an estimated $648K and leaving 130,993 shares worth $2.96M. The position accounts for 0.01% of the portfolio, ranked #1218.
State of Wisconsin Investment Board first reported a position in PCRX in Q2 2017 and has held it in 36 quarters since. The position peaked at $4.5M in Q1 2022. 241 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.
- State of Wisconsin Investment Board held 130,993 shares of Pacira BioSciences worth $2.96M as of Q1 2026.
- State of Wisconsin Investment Board sold 29,171 Pacira BioSciences shares in Q1 2026, an estimated $648K.
- Pacira BioSciences made up 0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1218 holding.
- State of Wisconsin Investment Board first reported a position in Pacira BioSciences in Q2 2017 and has held it in 36 quarters since.
- State of Wisconsin Investment Board's Pacira BioSciences position peaked at $4.5M in Q1 2022.
- 241 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.
Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.